Vascular Surgery, The University of Tokyo

研究

Medical Research

The motto of the Department of Vascular Surgery, The University of Tokyo is “treatments based on scientific evidence”. This evidence is derived from research. In modern Japanese medical history, our department has published a lot of research results and is recognized as a front-runner in the field of vascular surgery. Based on the evidence obtained, we are convinced that we are applying it to clinical treatment.

Research collaboration (including Medicine-Engineering collaboration)

当科の研究は現在他施設との連携(主に医工)によるものが多く、次々と成果をあげています。

Drug Delivery System using nanoparticles

CABRAL Horacio准教授

Cabral Horacio
Associate Professor
Department of Materials Engineering, The University of Tokyo
Cabral lab: http://www.bmc.t.u-tokyo.ac.jp/index-e.html

片岡一則教授

Kazunori Kataoka (from 2009 to 2015)
Director General, Innovation Center of NanoMed; Professor, IFI, The University of Tokyo
https://iconm.kawasaki-net.ne.jp/kklab/index-e.html

Research example (1)

Prevention of aortic aneurysm dilatation with drug delivery system using Nanomicelles

[Summary] Currently, there is no method to control the dilation of aortic aneurysms. We have continued research on ways to prevent rupture of aortic aneurysms without surgery. Aortic aneurysm models in rats have been available since the 1990s, and there have been a series of reports that various drugs could be effective for preventing the dilation of the aneurysm “in animals”. However, there are no reports on the effectiveness of the drug in humans. The dose of the drug might be too high to be safely administered to humans.

To reduce the dose of the drug, we encapsulated it in nanoparticles and administered using the drug delivery system. The nanoparticles then stay in the relatively structurally coarse inflamed wall of the aortic aneurysm, where they release the drug. We succeeded in preventing aneurysm dilatation by using nanoparticles containing a drug called rapamycin (anti-inflammatory drug). There are still some points to be addressed, such as confirming the toxicity of the drug in humans, before it can be applied in clinical practice. However, I believe that in the near future, the “medication” option for patients with a high risk of aortic surgery will be chosen.

Prevention of aortic aneurysm dilatation with drug delivery system using Nanomicelles

Analysis using motion capture for the patients of peripheral arterial disease

中村仁彦教授

Yoshihiko Nakamura
Professor
Dynamics control systems lab
Department of Mechano-informatics, University of Tokyo
http://www.ynl.t.u-tokyo.ac.jp/wp/http://www.ynl.t.u-tokyo.ac.jp/wp/

Research example (2)

Three-dimensional motion analysis using motion capture for patients with peripheral arterial disease: improvement after the bicycle exercise training

[Summary] Symptoms of intermittent claudication in patients with peripheral arterial disease can be improved by exercise. It was speculated that the improvement may be due to the increase in collateral vessels; however, the details have not yet been clarified. We analyzed the 3D movement during walking in patients with claudication using “motion capture” before and after the bicycle exercise. In addition, we measured the volume of muscles related to walking movement using CT. As a result, we found that the efficiency of walking was improved by increasing the muscle strength of the lumbar region and thigh, and reducing factors such as the expansion of the range of motion of the hip joint and maximum muscle tone. We assume that this novel finding will help the exercise program improve and be more scientific in future.

Three-dimensional motion analysis using motion capture for patients with peripheral arterial disease: improvement after the bicycle exercise training

Aortic Aneurysm Simulation Study Group

Introduction video of the society: A TV program named “Yume-no-Tobira (Door of dream)” (TBS)

大島まり教授

Marie Oshima
Professor
Oshima Lab
Institute of Industrial Science, The University of Tokyo
http://www.oshimalab.iis.u-tokyo.ac.jp/japanese/

山本創太教授

Sota Yamamoto
Professor
Department of Mechanical Engineering, Shibaura Institute of Technology
http://www.meo.shibaura-it.ac.jp/lab_yamamoto.html

Research example (3)

What is a “saccular”?

[Summary] The diameter of the aortic aneurysm is the most important factor for surgical intervention. The shape of the aneurysm is also an important factor. Saccular (protruding) morphology is believed to have a higher risk of rupture than the fusiform shape. However, even small aortic aneurysms were sometimes operated under the diagnosis of “saccular” aneurysm. Interestingly, how was the “saccular” aneurysm diagnosed? We suspect that there were some patients with aortic aneurysms that were diagnosed as saccular and underwent surgery, but could have been diagnosed as fusiform by other doctors and actually have little risk of rupture. In such cases, were unnecessary operations performed? In the era of endovascular treatment, it has become easier to perform surgery, and it seems that small aneurysms with less risk of rupture are being treated. Surgery is the last resort. The judgment of such important morphology related to the surgical intervention should be strictly and scientifically determined.

The definition of “saccular” has never been scientifically defined. In our department, we created a model of aortic aneurysm and proposed a definition of saccular aneurysm. One definition is “the protrusion ellipse (aneurysm) is horizontally long.” When combined with the actual aortic aneurysm data, we found that the saccular aneurysm group according to our definition had a significantly faster expansion rate. We should pursue evidence with the Medical-Engineering Collaboration, which is under the responsibility of the Aortic Aneurysm Simulation Study Group.

What is a “saccular”?

Application of the hybrid gel for the artificial graft

田口光正上席研究員

Mitsumasa Taguchi
Senior Scientist
Takasaki Advanced Radiation Research Institute, Quantum Beam Science Research Directorate, National Institutes for Quantum and Radiological Science and Technology
(QST)

Hemostasis with Tetra-PEG gel

酒井崇匡准教授

Takamasa Sakai
Associate Professor
Department of Bioengineering, Graduate School of Engineering, The University of Tokyo
http://www.tetrapod.t.u-tokyo.ac.jp/sakai/saito/Main.html

Arteriovenous shunt creation in rats and vascular remodeling

Professor Alan Dardik

Alan Dardik
Professor
Yale University, Department of Vascular Surgery
https://medicine.yale.edu/lab/dardik/

Research example (4)

Arteriovenous fistula creation for dialysis: basic research for long-term patency

[Summary] In Japan, the number of patients with chronic renal failure who receive hemodialysis therapy is increasing each year. AVF creation is the first-line of blood access for hemodialysis. Regarding AVF creation, failure of vessel maturation, stenosis, or occlusion of arteriovenous anastomosis sometimes occurs. The primary patency at 1 year after creation is 60%–65 %, which is one of the worst outcomes in all vascular surgeries. The cause of these failures is thought to be attributable to veins rather than arteries. Few studies have targeted veins in the field of vascular biology, and the detailed mechanism of maturation and failure has not been elucidated.

In Dr. Dardik Lab in the Department of Vascular Surgery, Yale University, to which our staff had belonged, we researched the process of adaptation of veins to the arterial environment using two models of AVF. The AVF model of mice was created and the results were presented by our staff (See figure). We collaborate with Dardik Lab and aim to clarify the molecular processes peculiar to AVFs and to improve the results of AVF surgery through further research.

Arteriovenous fistula creation for dialysis: basic research for long-term patency

Clinical and basic research in our department

倫理委員会での審査で承認されている臨床研究を下記に随時公開していきます。
(患者さんへの説明文書、同意・同意撤回、オプトアウト文書などは、課題ごとにリンクしています。)

◆ 3316-(4)

血管外科診療記録を利用したデータベースの包括的後ろ向き解析

◆ 3316-(4)

血管外科診療記録を利用したデータベースの包括的後ろ向き解析

◆ 3720-(2)

腹部大動脈ステントグラフト内挿術後の大動脈瘤およびデバイス形態のシミュレーション研究

◆ 3720-(2)

腹部大動脈ステントグラフト内挿術後の大動脈瘤およびデバイス形態のシミュレーション研究

◆ 10083-(2)

腹部大動脈瘤モデルの構造解析に基づいた臨床画像解析多施設研究

◆ 10083-(2)

腹部大動脈瘤モデルの構造解析に基づいた臨床画像解析多施設研究

◆ 10208-(2)

閉塞性動脈硬化症による間欠性跛行患者の歩行様式に関する研究

◆ 10208-(2)

閉塞性動脈硬化症による間欠性跛行患者の歩行様式に関する研究

◆ G2542-(10)

閉塞性動脈硬化症における個別化医療の実現

◆ G2542-(10)

閉塞性動脈硬化症における個別化医療の実現

◆ 10766

腹部大動脈瘤の破裂リスク予測における臨床研究(多施設共同研究)

◆ 10766

腹部大動脈瘤の破裂リスク予測における臨床研究(多施設共同研究)

◆ 10743-(2)

動脈硬化性病変における蛍光プローブライブラリーによる代謝反応特性スクリーニングに関する研究

◆ 10743-(2)

動脈硬化性病変における蛍光プローブライブラリーによる代謝反応特性スクリーニングに関する研究

◆ 11076-(1)

膝窩動脈捕捉症候群の診断、治療、管理を解析する多施設観察研究(多施設共同後向き観察研究)

◆ 11076-(1)

膝窩動脈捕捉症候群の診断、治療、管理を解析する多施設観察研究(多施設共同後向き観察研究)

◆ 11411

腹部大動脈瘤・腸骨動脈瘤術後の臀筋跛行患者における運動療法の介入研究

◆ 11411

腹部大動脈瘤・腸骨動脈瘤術後の臀筋跛行患者における運動療法の介入研究

◆ 11567

血管外科のOff the Job Trainingの手法とその評価

◆ 11567

血管外科のOff the Job Trainingの手法とその評価

◆ 11595

動脈硬化性病変における蛍光プローブライブラリーによる代謝反応特性スクリーニングに関する研究

◆ 11595

動脈硬化性病変における蛍光プローブライブラリーによる代謝反応特性スクリーニングに関する研究

◆ 2018002NI

破裂性腹部大動脈瘤に対する開腹手術とステントグラフト内挿術の治療選択に関する全国多施設観察研究

◆ 2018002NI

破裂性腹部大動脈瘤に対する開腹手術とステントグラフト内挿術の治療選択に関する全国多施設観察研究